Insider Transactions in Q2 2025 at Rocket Pharmaceuticals, Inc. (RCKT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
587
-0.39%
|
$3,522
$6.45 P/Share
|
|
May 20
2025
|
Gaurav Shah CEO |
SELL
Open market or private sale
|
Direct |
2,253
-0.29%
|
$13,518
$6.45 P/Share
|
|
May 20
2025
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
767
-0.17%
|
$4,602
$6.45 P/Share
|
|
May 20
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
801
-0.34%
|
$4,806
$6.45 P/Share
|
|
May 20
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
357
-0.55%
|
$2,142
$6.45 P/Share
|
|
May 16
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
946
-0.63%
|
$5,676
$6.53 P/Share
|
|
May 16
2025
|
Gaurav Shah CEO |
SELL
Open market or private sale
|
Direct |
3,621
-0.46%
|
$21,726
$6.53 P/Share
|
|
May 16
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
1,582
-0.67%
|
$9,492
$6.53 P/Share
|
|
May 16
2025
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
1,409
-0.32%
|
$8,454
$6.53 P/Share
|
|
May 16
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
655
-1.01%
|
$3,930
$6.53 P/Share
|
|
Apr 22
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
718
-1.09%
|
$5,026
$7.16 P/Share
|
|
Apr 10
2025
|
Gaurav Shah CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+2.46%
|
$100,000
$5.08 P/Share
|
|
Apr 09
2025
|
Kinnari Patel |
BUY
Open market or private purchase
|
Indirect |
21,099
+44.07%
|
$84,396
$4.7 P/Share
|
|
Apr 04
2025
|
Aaron Ondrey Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,489
-5.46%
|
$37,445
$5.29 P/Share
|